ABIVAX Société Anonyme (0RA9.L)

EUR 6.51

(0.46%)

Total Assets Summary of ABIVAX Société Anonyme

ABIVAX Société Anonyme's latest annual total assets in 2023 was 327.06 Million EUR , up 345.88% from previous year.
ABIVAX Société Anonyme's latest quarterly total assets in 2024 Q2 was 284.49 Million EUR , down 0.0% from previous quarter.
ABIVAX Société Anonyme reported annual total assets of 73.35 Million EUR in 2022, down -33.54% from previous year.
ABIVAX Société Anonyme reported annual total assets of 110.36 Million EUR in 2021, up 54.79% from previous year.
ABIVAX Société Anonyme reported quarterly total assets of 327.06 Million EUR for 2023 Q4, down 0.0% from previous quarter.
ABIVAX Société Anonyme reported quarterly total assets of 327.06 Million EUR for 2023 FY, up 345.88% from previous quarter.

Annual Total Assets Chart of ABIVAX Société Anonyme (2023 - 2013)

Historical Annual Total Assets of ABIVAX Société Anonyme (2023 - 2013)

Year	Total Assets	Total Assets Growth
2023	327.06 Million EUR	345.88%
2022	73.35 Million EUR	-33.54%
2021	110.36 Million EUR	54.79%
2020	71.29 Million EUR	37.83%
2019	51.72 Million EUR	-4.29%
2018	54.04 Million EUR	0.43%
2017	53.81 Million EUR	-11.19%
2016	60.59 Million EUR	-20.55%
2015	76.26 Million EUR	100.88%
2014	37.96 Million EUR	-1.29%
2013	38.46 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	284.49 Million EUR	0.0%
2023 Q4	327.06 Million EUR	0.0%
2023 FY	327.06 Million EUR	345.88%
2023 Q2	171.1 Million EUR	0.0%
2022 Q2	71.64 Million EUR	0.0%
2022 Q4	73.35 Million EUR	0.0%
2022 FY	73.35 Million EUR	-33.54%
2021 FY	110.36 Million EUR	54.79%
2021 Q2	55.09 Million EUR	0.0%
2021 Q4	110.36 Million EUR	0.0%
2020 FY	71.29 Million EUR	37.83%
2020 Q2	49.81 Million EUR	0.0%
2020 Q4	71.29 Million EUR	0.0%
2019 Q4	51.72 Million EUR	0.0%
2019 FY	51.72 Million EUR	-4.29%
2019 Q2	54.59 Million EUR	0.0%
2018 Q2	46.04 Million EUR	0.0%
2018 FY	54.04 Million EUR	0.43%
2018 Q4	54.04 Million EUR	0.0%
2017 Q4	53.81 Million EUR	0.0%
2017 FY	53.81 Million EUR	-11.19%
2017 Q2	55.18 Million EUR	0.0%
2016 Q4	60.59 Million EUR	0.0%
2016 Q2	66.66 Million EUR	0.0%
2016 FY	60.59 Million EUR	-20.55%
2015 Q4	76.26 Million EUR	0.0%
2015 FY	76.26 Million EUR	100.88%
2015 Q2	89.35 Million EUR	0.0%
2014 Q4	37.96 Million EUR	0.0%
2014 Q3	- EUR	0.0%
2014 FY	37.96 Million EUR	-1.29%
2014 Q1	- EUR	0.0%
2013 FY	38.46 Million EUR	0.0%

Peer Total Assets Comparison of ABIVAX Société Anonyme

Name	Total Assets	Total Assets Difference
Boiron SA	590.2 Million EUR	44.585%
Laboratorios Farmaceuticos Rovi, S.A.	799.88 Million EUR	59.111%
Vetoquinol SA	692.23 Million EUR	52.753%
Valneva SE	469.39 Million EUR	30.322%
AB Science S.A.	25.49 Million EUR	-1182.646%
Nanobiotix S.A.	93.89 Million EUR	-248.32%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	-537.461%
Vivoryon Therapeutics N.V.	30.82 Million EUR	-960.891%
BioSenic S.A.	9.55 Million EUR	-3321.509%
Formycon AG	890.36 Million EUR	63.266%